MG
ELV icon

Marex Group’s Elevance Health ELV Stock Holding History

Marex Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$572K Sell
1,478
-87
-6% -$32.3K ﹤0.01% 658
2026
Q1 		$458K Buy
1,565
+395
+34% +$130K ﹤0.01% 650
2025
Q4 		$410K Sell
1,170
-330
-22% -$112K ﹤0.01% 619
2025
Q3 		$485K Buy
+1,500
New +$467K ﹤0.01% 506
2025
Q2 		– Sell
-73,501
Closed -$32M – 738
2025
Q1 		$32M Buy
73,501
+23,501
+47% +$9.43M 0.61% 36
2024
Q4 		$18.4M Sell
50,000
-2,215
-4% -$927K 0.31% 58
2024
Q3 		$27.2M Sell
52,215
-26,190
-33% -$14M 0.62% 38
2024
Q2 		$42.5M Buy
+78,405
New +$41.4M 1.14% 19
2024
Q1 		– Sell
-3,735
Closed -$1.76M – 562
2023
Q4 		$1.76M Buy
+3,735
New +$1.73M 0.07% 169

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Marex Group's ELV Position: Q2 2026 in Review

Marex Group reduced its Elevance Health (ELV) stake by 5.6% in Q2 2026, selling an estimated $32.3K and leaving 1,478 shares worth $572K. The position accounts for ﹤0.01% of the portfolio, ranked #658.

Marex Group first reported a position in ELV in Q4 2023 and has held it in 9 quarters since. The position peaked at $42.5M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Marex Group held 1,478 shares of Elevance Health worth $572K as of Q2 2026.
  • Marex Group sold 87 Elevance Health shares in Q2 2026, an estimated $32.3K.
  • Elevance Health made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #658 holding.
  • Marex Group first reported a position in Elevance Health in Q4 2023 and has held it in 9 quarters since.
  • Marex Group's Elevance Health position peaked at $42.5M in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.